Overview

PRevention of Macular EDema After Cataract Surgery

Status:
Completed
Trial end date:
2016-11-04
Target enrollment:
Participant gender:
Summary
Cystoid macular edema (CME) is a common cause of vision loss after cataract surgery. In the last few years, several new treatments have been tried to address the problem of CME after cataract surgery in diabetic and non-diabetic patients. The investigators will perform a large RCT with the aim to provide more definite evidence-based recommendations for clinical guidelines to prevent the occurrence of CME after cataract surgery in patients with and without diabetes mellitus (DM).
Phase:
Phase 3
Details
Lead Sponsor:
Maastricht University Medical Center
Collaborator:
European Society of Cataract and Refractive Surgeons
Treatments:
BB 1101
Bevacizumab
Bromfenac
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Ophthalmic Solutions
Tetrahydrozoline
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide